Publications: Mr Joseph Gibbons
Riddell AC, Kele B, Harris K, Bible J, Murphy M, Dakshina S, Storey N, Owoyemi D et al.
(
2022
)
.
Generation of Novel Severe Acute Respiratory Syndrome Coronavirus 2 Variants on the B.1.1.7 Lineage in 3 Patients With Advanced Human Immunodeficiency Virus-1 Disease
.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
vol.
75
,
(
11
)
2016
-
2018
.
Vivaldi G, Jolliffe DA, Faustini S, Shields AM, Holt H, Perdek N, Talaei M, Tydeman F et al.
(
2022
)
.
Correlation Between Postvaccination Anti-Spike Antibody Titers and Protection Against Breakthrough Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Population-Based Longitudinal Study
.
The Journal of infectious diseases
vol.
226
,
(
11
)
1903
-
1908
.
Captur G, Moon JC, Topriceanu CC, Joy G, Swadling L, Hallqvist J, Doykov I, Patel N et al.
(
2022
)
.
Plasma proteomic signature predicts who will get persistent symptoms following SARS-CoV-2 infection
.
eBioMedicine
vol.
85
,
Doykov I, Baldwin T, Spiewak J, Gilmour KC, Gibbons JM, Pade C, Reynolds CJ, Áine McKnight et al.
(
2022
)
.
Quantitative, multiplexed, targeted proteomics for ascertaining variant specific SARS-CoV-2 antibody response
.
Cell Reports Methods
vol.
2
,
(
9
)
Jolliffe DA, Vivaldi G, Chambers ES, Cai W, Li W, Faustini SE, Gibbons JM, Pade C et al.
(
2022
)
.
Vitamin D Supplementation Does Not Influence SARS-CoV-2 Vaccine Efficacy or Immunogenicity: Sub-Studies Nested within the CORONAVIT Randomised Controlled Trial
.
Nutrients
vol.
14
,
(
18
)
Reynolds CJ, Pade C, Gibbons JM, Otter AD, Lin KM, Sandoval DM, Pieper FP, Butler DK et al.
(
2022
)
.
Immune boosting by B.1.1.529 (Omicron) depends on previous SARS-CoV-2 exposure
.
Science
vol.
377
,
(
6603
)
Astbury S, Reynolds CJ, Butler DK, Muñoz-Sandoval DC, Lin KM, Pieper FP, Otter A, Kouraki A et al.
(
2022
)
.
HLA-DR polymorphism in SARS-CoV-2 infection and susceptibility to symptomatic COVID-19
.
Immunology
vol.
166
,
(
1
)
68
-
77
.
Chandran A, Rosenheim J, Nageswaran G, Swadling L, Pollara G, Gupta RK, Burton AR, Guerra-Assunção JA et al.
(
2022
)
.
Rapid synchronous type 1 IFN and virus-specific T cell responses characterize first wave non-severe SARS-CoV-2 infections
.
Cell Reports Medicine
vol.
3
,
(
3
)
Reynolds CJ, Gibbons JM, Pade C, Lin KM, Sandoval DM, Pieper F, Butler DK, Liu S et al.
(
2022
)
.
Heterologous infection and vaccination shapes immunity against SARS-CoV-2 variants
.
Science
vol.
375
,
(
6577
)
183
-
192
.
Usai C, Gibbons JM, Pade C, Li W, Jacobs SRM, McKnight A, Kennedy PTF, Gill US
(
2022
)
.
The β-NGF/TrkA Signalling Pathway Is Associated With the Production of Anti-Nucleoprotein IgG in Convalescent COVID-19
.
Frontiers in Immunology
vol.
12
,
Swadling L, Diniz MO, Schmidt NM, Amin OE, Chandran A, Shaw E, Pade C, Gibbons JM et al.
(
2021
)
.
Pre-existing polymerase-specific T cells expand in abortive seronegative SARS-CoV-2
.
Nature
Joy G, Artico J, Kurdi H, Seraphim A, Lau C, Thornton GD, Oliveira MF, Adam RD et al.
(
2021
)
.
Prospective Case-Control Study of Cardiovascular Abnormalities 6 Months Following Mild COVID-19 in Healthcare Workers
.
JACC: Cardiovascular Imaging
vol.
14
,
(
11
)
2155
-
2166
.
Gupta RK, Rosenheim J, Bell LC, Chandran A, Guerra-Assuncao JA, Pollara G, Whelan M, Artico J et al.
(
2021
)
.
Blood transcriptional biomarkers of acute viral infection for detection of pre-symptomatic SARS-CoV-2 infection: a nested, case-control diagnostic accuracy study
.
Lancet Microbe
vol.
2
,
(
10
)
e508
-
e517
.
Swadling L, Diniz M, Schmidt N, Amin O, Chandran A, Shaw E, Pade C, Gibbons J et al.
(
2021
)
.
Pre-existing polymerase-specific T cells expand in abortive seronegative SARS-CoV-2 infection
.
Reynolds CJ, Pade C, Gibbons JM, Butler DK, Otter AD, Menacho K, Fontana M, Smit A et al.
(
2021
)
.
Prior SARS-CoV-2 infection rescues B and T cell responses to variants after first vaccine dose
.
Science
vol.
372
,
(
6549
)
1418
-
1423
.
Manisty C, Treibel TA, Jensen M, Semper A, Joy G, Gupta RK, Cutino-Moguel T, Andiapen M et al.
(
2021
)
.
Time series analysis and mechanistic modelling of heterogeneity and sero-reversion in antibody responses to mild SARS‑CoV-2 infection
.
EBioMedicine
vol.
65
,
Reynolds CJ, Swadling L, Gibbons JM, Pade C, Jensen MP, Diniz MO, Schmidt NM, Butler DK et al.
(
2020
)
.
Discordant neutralizing antibody and T cell responses in asymptomatic and mild SARS-CoV-2 infection
.
Science Immunology
vol.
5
,
(
54
)
Manisty C, Treibel TA, Jensen M, Semper A, Joy G, Gupta RK, Cutino-Moguel T, Andiapen M et al.
(
2020
)
.
Characterising heterogeneity and sero-reversion in antibody responses to mild SARS⍰CoV-2 infection: a cohort study using time series analysis and mechanistic modelling
.
Reynolds C, Swadling L, Gibbons J, Pade C, Jensen M, Diniz M, Schmidt N, Butler D et al.
(
2020
)
.
Healthcare workers with mild / asymptomatic SARS-CoV-2 infection show T cell responses and neutralising antibodies after the first wave
.
Augusto JB, Menacho K, Andiapen M, Bowles R, Burton M, Welch S, Bhuva AN, Seraphim A et al.
(
2020
)
.
Healthcare Workers Bioresource: Study outline and baseline characteristics of a prospective healthcare worker cohort to study immune protection and pathogenesis in COVID-19
.
Wellcome Open Research
vol.
5
,
179
-
179
.
Gibbons JM, Marno KM, Pike R, Lee WYJ, Jones CE, Ogunkolade BW, Pardieu C, Bryan A et al.
(
2020
)
.
HIV-1 accessory protein Vpr interacts with ReaF/RPRD2 to mitigate its antiviral activity
.
Journal of Virology
vol.
94
,
(
4
)
Gibbons J, Marno K, Pike R, Lee J, Jones C, Ogunkolade W, Pardieu C, Warnes G et al.
(
2019
)
.
HIV-1 Vpr accessory protein interacts with REAF and mitigates its associated anti-viral activity
.
Access Microbiology
vol.
1
,
(
1A
)
Gibbons J, Lee W-YJ, McKnight Á
(
2019
)
.
HIV-1 infectivity of cells is enhanced at mitosis: a role for Vpr?
.
Access Microbiology
vol.
1
,
(
1A
)
Gibbons J, Marno K, Pike R, Lee W-YJ, Jones C, Ogunkolade B, Pardieu C, Bryan A et al.
(
2018
)
.
HIV-1 accessory protein Vpr interacts with REAF/RPRD2 to mitigate its antiviral activity
.